Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Head and Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Large-scale testing (Phase 3)Looking for participantsNCT07441681
What this trial is testing

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+13 more
NRG Oncology
Early research (Phase 1)Ended earlyNCT01871311
What this trial is testing

A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck Cancer
Georgetown University 15
Testing effectiveness (Phase 2)Ended earlyNCT05110781
What this trial is testing

Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckResectable Cutaneous Squamous Cell Carcinoma of the Head and NeckStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
University of California, Davis 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861712
What this trial is testing

Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Stereotactic Body Radiation Therapy (SBRT)
Sun Yat-sen University 50
Not applicableStudy completedNCT00482872
What this trial is testing

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 400
Large-scale testing (Phase 3)Study completedNCT00003139
What this trial is testing

Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral Complications
Radiation Therapy Oncology Group 249
Testing effectiveness (Phase 2)Study completedNCT05517330
What this trial is testing

Neoadjuvant Tislelizumab With Afatinib for Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
West China Hospital 23
Early research (Phase 1)Ended earlyNCT01987375
What this trial is testing

Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures

Who this might be right for
Head and Neck Cancer
Eben Rosenthal 1
Testing effectiveness (Phase 2)Study completedNCT03723967
What this trial is testing

FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Centre Leon Berard 104
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683507
What this trial is testing

Becotatug Vedotin Plus PD-1 Inhibitor for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Feng Liu 60
Testing effectiveness (Phase 2)Study completedNCT02949700
What this trial is testing

Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Baylor College of Medicine 26
Early research (Phase 1)WithdrawnNCT03575234
What this trial is testing

Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer

Who this might be right for
Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+2 more
Emory University
Large-scale testing (Phase 3)UnknownNCT00002884
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Centre Hospitalier Lyon Sud 326
Testing effectiveness (Phase 2)Study completedNCT00720304
What this trial is testing

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 43
Testing effectiveness (Phase 2)Looking for participantsNCT07481058
What this trial is testing

KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Beijing Konruns Pharmaceutical Co., Ltd. 60
Not applicableStudy completedNCT01487733
What this trial is testing

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 155
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Active Not RecruitingNCT05238883
What this trial is testing

HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Who this might be right for
Gastric CancerRenal Cell CarcinomaMelanoma+6 more
HiFiBiO Therapeutics 72
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Next Page
454